S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
NASDAQ:IIN

IntriCon Stock Forecast, Price & News

$20.05
-0.69 (-3.33 %)
(As of 09/24/2021 04:00 PM ET)
Add
Compare
Today's Range
$20.01
$20.72
50-Day Range
$20.05
$24.00
52-Week Range
$11.62
$28.16
Volume14,303 shs
Average Volume49,645 shs
Market Capitalization$182.39 million
P/E Ratio154.24
Dividend YieldN/A
Beta1.27
30 days | 90 days | 365 days | Advanced Chart
Receive IIN News and Ratings via Email

Sign-up to receive the latest news and ratings for IntriCon and its competitors with MarketBeat's FREE daily newsletter.


IntriCon logo

About IntriCon

Intricon Corp. engages in the design, development, engineering, manufacture, and distribution of miniature and micro-miniature body-worn devices. It operates through the Body-Worn Device and Hearing Health Direct-To-End Consumer segments. The Body-Worn Device segment comprises medical, hearing health, and professional audio markets. The Hearing Health Direct-To-End Consumer segment provides advanced hearing products such as ultra-miniature volume controls and trimmers, custom amplifiers, and custom, completed hearing instruments. The company was founded in 1930 and is headquartered in Arden Hills, MN.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.25 out of 5 stars

Computer And Technology Sector

244th out of 860 stocks

Electronic Components & Accessories Industry

5th out of 11 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











IntriCon (NASDAQ:IIN) Frequently Asked Questions

Is IntriCon a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IntriCon in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" IntriCon stock.
View analyst ratings for IntriCon
or view top-rated stocks.

What stocks does MarketBeat like better than IntriCon?

Wall Street analysts have given IntriCon a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but IntriCon wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is IntriCon's next earnings date?

IntriCon is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for IntriCon
.

How were IntriCon's earnings last quarter?

IntriCon Co. (NASDAQ:IIN) issued its earnings results on Monday, August, 9th. The technology company reported $0.23 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.08 by $0.15. The technology company earned $30.22 million during the quarter, compared to analysts' expectations of $28.58 million. IntriCon had a net margin of 1.06% and a trailing twelve-month return on equity of 7.00%.
View IntriCon's earnings history
.

How has IntriCon's stock been impacted by COVID-19?

IntriCon's stock was trading at $12.34 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IIN shares have increased by 62.5% and is now trading at $20.05.
View which stocks have been most impacted by COVID-19
.

What guidance has IntriCon issued on next quarter's earnings?

IntriCon issued an update on its FY 2021 earnings guidance on Monday, September, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $121 million-$125 million, compared to the consensus revenue estimate of $121.02 million.

What price target have analysts set for IIN?

2 Wall Street analysts have issued 12 month price targets for IntriCon's shares. Their forecasts range from $27.00 to $32.00. On average, they expect IntriCon's stock price to reach $29.50 in the next year. This suggests a possible upside of 47.1% from the stock's current price.
View analysts' price targets for IntriCon
or view top-rated stocks among Wall Street analysts.

Who are IntriCon's key executives?

IntriCon's management team includes the following people:
  • J. Scott Longval, President, Chief Executive Officer & Director
  • Dennis L. Gonsior, Senior Vice President-Operations (LinkedIn Profile)
  • Ellen Scipta, Chief Financial Officer
  • Doug Pletcher, Vice President-Medical Business Development
  • David Liebl, Vice President-Research & Development

What is Mark S. Gorder's approval rating as IntriCon's CEO?

7 employees have rated IntriCon CEO Mark S. Gorder on Glassdoor.com. Mark S. Gorder has an approval rating of 100% among IntriCon's employees. This puts Mark S. Gorder in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of IntriCon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IntriCon investors own include Micron Technology (MU), Netflix (NFLX), Cisco Systems (CSCO), Dollar Tree (DLTR), Intel (INTC), NVIDIA (NVDA), UnitedHealth Group (UNH), Adobe (ADBE), Applied Materials (AMAT) and PayPal (PYPL).

What is IntriCon's stock symbol?

IntriCon trades on the NASDAQ under the ticker symbol "IIN."

Who are IntriCon's major shareholders?

IntriCon's stock is owned by many different retail and institutional investors. Top institutional investors include Gamco Investors INC. ET AL (5.86%), Palisade Capital Management LLC NJ (5.01%), Vanguard Group Inc. (4.42%), Dimensional Fund Advisors LP (4.18%), Mairs & Power Inc. (4.09%) and Millennium Management LLC (2.68%). Company insiders that own IntriCon stock include Dennis Gonsior and Michael Geraci.
View institutional ownership trends for IntriCon
.

Which major investors are selling IntriCon stock?

IIN stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., State Street Corp, Russell Investments Group Ltd., Northern Trust Corp, Geode Capital Management LLC, Vanguard Group Inc., JPMorgan Chase & Co., and Bank of New York Mellon Corp. Company insiders that have sold IntriCon company stock in the last year include Dennis Gonsior, and Michael Geraci.
View insider buying and selling activity for IntriCon
or view top insider-selling stocks.

Which major investors are buying IntriCon stock?

IIN stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Renaissance Technologies LLC, Franklin Resources Inc., Bank of Montreal Can, Ergoteles LLC, Gamco Investors INC. ET AL, Susquehanna International Group LLP, and Acuitas Investments LLC.
View insider buying and selling activity for IntriCon
or or view top insider-buying stocks.

How do I buy shares of IntriCon?

Shares of IIN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IntriCon's stock price today?

One share of IIN stock can currently be purchased for approximately $20.05.

How much money does IntriCon make?

IntriCon has a market capitalization of $182.39 million and generates $102.77 million in revenue each year. The technology company earns $-2,520,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.

How many employees does IntriCon have?

IntriCon employs 762 workers across the globe.

What is IntriCon's official website?

The official website for IntriCon is www.intricon.com.

Where are IntriCon's headquarters?

IntriCon is headquartered at 1260 RED FOX ROAD, ARDEN HILLS MN, 55112.

How can I contact IntriCon?

IntriCon's mailing address is 1260 RED FOX ROAD, ARDEN HILLS MN, 55112. The technology company can be reached via phone at (651) 636-9770 or via email at [email protected].


This page was last updated on 9/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.